Evren Alici
John Rossi
Dan Kaufman
Jason Litten
Laura Schulman
I love the food world. All of it. I love the passionate people who put their hearts and souls into building brands. The immense talent I get to know and work with – industry veterans, dietitians, chefs, start-ups, non-profits – and individuals who have a common interest in creating a more exciting, more diverse and more sustainable food system for the future.
I have spent more than two decades in this world, and where I am today is truly the best part of the journey. I started my own firm in 2019 with the goal of doing what I do best, enjoying my work and making an impact. I learned so much working at the best global PR firms in the world (Weber Shandwick, Edelman, Burson Marsteller) on best-in-class clients including PepsiCo, Quaker, Campbell Soup Company, Oreo, Kraft, ADM, Cherry Marketing Institute and National Confectioners Association. And, it’s how I met my co-founder Etienne Hernandez – Medina who I’m proud to be partnering with on food forward work.
In my most recent role as an SVP, Partner at FleishmanHillard, I built and ran the Chicago office’s multi-million-dollar Food & Nutrition practice from the ground up. I started Food Futures Strategies. Now it was time to build something of my own. I created Crave It PR with my co-founder, colleague and friend Etienne Hernandez-Medina, the CEO of H+M Communications, to put game-changing brands front and center in today’s food culture, and grow their relevance and revenue in new, exciting ways.
Xiaozhang Zheng
Profile
Accomplished drug discovery leader with twenty years of pharmaceutical industry experience in the discovery and early development of small molecule therapeutics in oncology, inflammation, CNS, and other therapeutic areas. Ability to successfully deliver projects to achieve research and company goals including clinical trials, IND-enabling studies, and partnerships.
Education
Ph.D. , Medicinal Chemistry, University of Tennessee, Memphis, TN
Dissertation: Novel Antithrombotic Compounds: Synthesis, Stereochemistry, and Structure-Activity Relationships of Antiplatelet 3-Carbamoylpiperidines
Patents & Publications
Over 40 published patent applications and 20 US granted patents
37 publications
Tasuku Ishida
Tasuku Ishida completed his M.S.(2002) and Ph.D.(2005) at the University of Tokyo supervised by Prof. Shu Kobayashi. After obtained Ph.D. degree, he joined Eisai Co,. Ltd. as a medicinal chemist to develop new chemical entities in neuroscience area. In 2011, he was assigned to H3 Biomedicine Inc. in Massachusetts, US, which is one of Eisai’s subsidiary, as a senior investigator to construct diversity-oriented synthesis (DOS) library. After coming back to Japan in 2015, he joined Oncology Business Group as a senior scientist to develop novel cancer therapies. In 2019, he moved to the UK for the collaborative project between the Prof. Alessio Ciulli group and Eisai to develop novel types of protein degraders.